We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bariatric Surgery Bests Medical Therapy for Diabetes

By HospiMedica International staff writers
Posted on 10 Jun 2014
A new study shows bariatric surgery is a highly effective and durable treatment for diabetes mellitus type 2 (DM2) in obese patients, enabling nearly all surgical patients to be free of insulin three years after surgery.

Researchers at the Cleveland Clinic (OH, USA) assessed outcomes three years after the randomization of 150 obese patients with uncontrolled DM2 to receive either intensive medical therapy alone (50 participants), intensive medical therapy plus Roux-en-Y gastric bypass (50 participants), or intensive medical therapy plus sleeve gastrectomy (50 participants). More...
The primary end point was a hemoglobin A1c (HbA1c) level of less than or equal to 6%.

The results showed that at the three-year mark, more patients in the gastric bypass group (37.5%) achieved blood sugar control without the use of any diabetic medications compared with those that received intensive medical therapy alone (5%), or in those in the sleeve gastrectomy group (24.5%). The study also revealed significant improvements in five of eight mental and physical domains for patients in the gastric bypass group, and two of eight domains for the patients in the sleeve gastrectomy group; there was no improvement in the medical therapy group. The study was published on May 22, 2014, in the New England Journal of Medicine (NEJM).

"We looked at quality of life, because ultimately it is all about helping our patients live a healthier, happier life,” said lead author Philip Schauer, MD, director of the Cleveland Clinic Bariatric and Metabolic Institute. “When compared to sleeve gastrectomy and medical therapy, gastric bypass patients achieved greater weight loss, were on fewer medications, had a higher success rate in controlling their diabetes, and an improved quality of life."

“We see patients whose lives are ravaged by diabetes,” added study author endocrinologist Sangeeta Kashyap, MD. “More than 90% of the patients who underwent bariatric surgery were able to lose 25% of their body weight and control their diabetes without the use of insulin and multiple diabetes drugs.”

DM2 is a metabolic disorder that is characterized by hyperglycemia in the context of insulin resistance and relative lack of insulin. This is in contrast to diabetes mellitus type 1, in which there is an absolute lack of insulin due to breakdown of islet cells in the pancreas. The classic symptoms are excess thirst, frequent urination, and constant hunger. DM2 makes up about 90% of cases of diabetes, with the other 10% due primarily to diabetes mellitus type 1 and gestational diabetes.

Related Links:

Cleveland Clinic



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.